![Irwin M. Rosenthal](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Irwin M. Rosenthal
Direttore/Membro del Consiglio presso EchoCath, Inc.
Posizioni attive di Irwin M. Rosenthal
Società | Posizione | Inizio | Fine |
---|---|---|---|
EchoCath, Inc.
![]() EchoCath, Inc. Medical SpecialtiesHealth Technology EchoCath, Inc. provides marketing medical devices, which enhance and expand the use of ultrasound technology for medical applications. It develops ultrasound technologies and characterizes blood flow and enables ultrasound imaging and identifying devices during interventional procedures such as needle biopsies and catheterizations. The company's technologies include a proprietary transcutaneous, epivascular and catheter based sensor and electronics system which provide data on the blood flow through internal vessels. EchoCath was founded on February 14, 1990 and is headquartered in Princeton, NJ. | Direttore/Membro del Consiglio | 15/03/2010 | - |
Segretario Aziendale | 15/03/2010 | - |
Storia della carriera di Irwin M. Rosenthal
Precedenti posizioni note di Irwin M. Rosenthal
Società | Posizione | Inizio | Fine |
---|---|---|---|
Greenberg Traurig LLP
![]() Greenberg Traurig LLP Miscellaneous Commercial ServicesCommercial Services Greenberg Traurig LLP provides legal services. The firm specializes in business aviation, futures and derivatives, financial regulatory and compliance, financial services litigation, project and infrastructure finance, public finance, restructuring, bankruptcy, and structured finance. The company was founded by Larry J. Hoffman, Mel Greenberg and Robert H. Traurig in 1967 and is headquartered in Miami, FL. | Corporate Officer/Principal | 15/03/2010 | - |
Conversion Technologies International, Inc.
![]() Conversion Technologies International, Inc. Industrial SpecialtiesProcess Industries Conversion Technologies International, Inc. develops, produces, and markets industrial abrasives. It also recycles glass used in televisions. The company was founded on August 20, 1997 and is headquartered in St. Augustine, FL. | Direttore/Membro del Consiglio | 13/08/2010 | - |
Independent Dir/Board Member | 01/05/1996 | - | |
SyntheMed, Inc.
![]() SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | Direttore/Membro del Consiglio | - | - |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Director/Board Member | 3 |
Corporate Secretary | 1 |
Corporate Officer/Principal | 1 |
Settori
Health Technology | 3 |
Commercial Services | 2 |
Process Industries | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
SyntheMed, Inc.
![]() SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | Health Technology |
EchoCath, Inc.
![]() EchoCath, Inc. Medical SpecialtiesHealth Technology EchoCath, Inc. provides marketing medical devices, which enhance and expand the use of ultrasound technology for medical applications. It develops ultrasound technologies and characterizes blood flow and enables ultrasound imaging and identifying devices during interventional procedures such as needle biopsies and catheterizations. The company's technologies include a proprietary transcutaneous, epivascular and catheter based sensor and electronics system which provide data on the blood flow through internal vessels. EchoCath was founded on February 14, 1990 and is headquartered in Princeton, NJ. | Health Technology |
Greenberg Traurig LLP
![]() Greenberg Traurig LLP Miscellaneous Commercial ServicesCommercial Services Greenberg Traurig LLP provides legal services. The firm specializes in business aviation, futures and derivatives, financial regulatory and compliance, financial services litigation, project and infrastructure finance, public finance, restructuring, bankruptcy, and structured finance. The company was founded by Larry J. Hoffman, Mel Greenberg and Robert H. Traurig in 1967 and is headquartered in Miami, FL. | Commercial Services |
Conversion Technologies International, Inc.
![]() Conversion Technologies International, Inc. Industrial SpecialtiesProcess Industries Conversion Technologies International, Inc. develops, produces, and markets industrial abrasives. It also recycles glass used in televisions. The company was founded on August 20, 1997 and is headquartered in St. Augustine, FL. | Process Industries |
- Borsa valori
- Insiders
- Irwin M. Rosenthal
- Esperienza